MLchartDataset catalogue

Phase 3 trial

Term · Environment · MLC-T-ENV-030774

Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects.

Table 1. Record
IdentifierMLC-T-ENV-030774
FieldEnvironment
SubjectResearch
Referencesafter FDA CDER handbook, ICH E8; CDISC-GLOSS
Record as JSON
{
  "id": "MLC-T-ENV-030774",
  "term": "Phase 3 trial",
  "field": "Environment",
  "term_source": "Phase 3 Trial",
  "definition": "Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects.",
  "subject": "Research",
  "references": [
    "after FDA CDER handbook, ICH E8; CDISC-GLOSS"
  ],
  "url": "https://mlchart.com/terminology/environment/phase-3-trial/"
}

Record 20,290 of 29,894 in Environment terminology (MLC-0121). Request the full dataset.